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Abstract 
 
This study was designed to investigate the activity of the enzyme 
glutathione peroxidase, level of malondialdehyde, biochemical parameters 
(total protein, albumin, uric acid, and conjugated and total bilirubin) and 
hematological parameters (red blood cells count, total white blood cells count, 
platelets count, hemoglobin, mean cell volume, mean cell hemoglobin, mean 
cell hemoglobin concentration and packed cell volume) in the blood of 
malaria patients. Forty patients infected with Plasmodium Falciparum malaria 
and ten healthy individuals (control group) were enrolled in this study in 
Sennar, Sudan, during 2010.   
The results indicated that 25% of malaria patients were 
thrombocytopenic.  The activity of the enzyme glutathione peroxidase was 
significantly different (P< 0.01) in platelets of the studied groups, the highest 
enzyme activity was observed for the control group (1979.0 U/L) followed by 
malaria non-thrombocytopenic (384.0 U/L) and the least was the malaria 
thrombocytopenic group (112.0U/L). On the other hand, the activity of the 
enzyme glutathione peroxidase was positively correlated with platelets count 
(r = 0.602; P < 0.01), and  negatively correlated with malondialdehyde            
(r = -0.36; P < 0.02). 
The level of malondialdehyde was significantly (P< 0.01) higher (7.3 
μmol/L) in the platelets of malaria thrombocytopenic patients than that of 
malaria non-thrombocytopenic patients (3.9μmol/L) and control group 
(0.0μmol/L).  Malondialdehyde was negatively correlated with platelets count  
(r = -0.7; P< 0.00).  
 There was a significant difference (P < 0.05) in total white blood cells 
between the studied groups, the highest count was observed for the non-
thrombocytopenic patients (7.9 X10
3
cell/mm
3
) compared to control            
X 
 
(6.1 X10
3
cell/mm
3
) and malaria thrombocytopenic group (5.1 X10
3
cell/mm
3
). 
The concentration of total bilirubin was significantly (P< 0.05)  increased in 
all malaria patients compared to the control group. Other measured 
biochemical parameters (total protein, albumin and uric acid) showed no 
significant difference between the studied groups. 
It is concluded that thrombocytopenia is associated with low activity 
of platelets glutathione peroxidase and high level of malondialdehyde. 
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 المستلخص
طََج هزٓ اىذساست ىيخحقق ٍِ ّشاط خَيشة جيىحاثيىُ بيشومسيذص و اىَاىىُ داي اىذيهايذ   
وغيشها ٍِ اىَعاىٌ اىنيَىحيىيت (اىبشوحيِ اىنيي، اىضلاه،حَض اىبىه، اىعظاسة اىظفشاويت اىَقخشّت 
ي، حعذاد خلايا و اىنييت) و اىَعاىٌ اىذٍىيت (حعذاد مشاث اىذً اىحَشاء، حعذاد خلايا اىذً اىبيضاء اىني
اىخثشيِ ،خضاب اىذً،ٍخىسظ حجٌ اىخييت، ٍخىسظ  خضاب اىخييت، ٍخىسظ حشميض اىخضاب ىيخييت ، 
 حجٌ اىخلايا اىَضغىعت) في دٍاء ٍشضي اىَلاسيا. 
سجو اسبعىُ ٍشيضا ٍظابيِ باىَلاسيا و عششة اشخاص اطحاء (شاهذ) ىيَشاسمت في    
 ً.2020لاه اىعاً اىسىداُ خ -اىذساست ورىل بَْغقت سْاس
وأُ ّشاط   % ٍِ ٍشضي اىَلاسيا يعاّىُ ٍِ عىص خلايا اىخثشيِ. 20اوضحج اىْخائج اُ  
 >Pاّضيٌ اىجيىحاثيىُ بيشومسيذيض في خلايا اىخثشيِ في اىَجَىعت اىَذسوست يخخيف اخخلافا ٍعْىيا (
ثٌ ٍشضي اىَلاسيا ) L/U 0.9791). حلاحظ اُ اعيي ّشاط ىلاّضيٌ ماُ في ٍجَىعت اىشاهذ (10.0
) واقو ّشاط ىلاّضيٌ وجذ ىذي ٍشضي اىَلاسيا L/U 0.483اىزيِ ىيس ىذيهٌ ّقض في خلايا اىخثشيِ (
 ).L/U0.211اىزيِ يعاّىُ ٍِ ّقض خلايا اىخثشيِ (
وٍِ ّاحيت اخشي فقذ اسحبظ ّشاط الاّضيٌ اىجيىحاثيىُ بيشومسيذيض اسحباعا  ٍىجبًا ٍع عذد 
 = r(- ;63.0و يشحبظ اسحباعا ساىبًا ٍع اىَاىىُ داي اىذيهايذ  = r()10.0 > P ;206.0  خلايا اىخثشيِ
 .)20.0 > P
ٍسخىي اىَاىىُ داي اىذيهايذ ماُ أعيي ٍعْىيا في خلايا اىخثشيِ ىَشضي عىص خلايا 
) ٍقاسّت ٍع ٍشضي اىَلايا اىزيِ لايعاّىُ عىص خلايا اىخثشيِ L/lomμ 3.7اىخثشيِ(
). و اسحبظ اىَاىىُ داي اىذيهايذ يشحبظ اسحباعا ساىبًا L/lomμ0.0عت اىشاهذ () و ٍجَىL/lomμ9.3(
 .  ))10.0>P ;7.0- = rٍع عذد خلايا اىخثشيِ 
أوضحج اىْخائج أُ هْاك اخخلافا  ٍعْىيًا بيِ اىعذد اىنيي ىخلايا اىذً اىبيضاء بيِ ٍجَىعاث  
 7.9، واعيي عذد ميي ماُ ىذي ٍشضي اىَلاسيا  اىزيِ لا  يعاّىُ ٍِ عىص خلايا اىخثشيِ( اىذساست
) و اىَشضي اىزيِ يعاّىُ ٍِ عىص خلايا 3خييت | ً ً  0.1) ٍقاسّت بَجَىعت اىشاهذ (  3خييت | ً ً 
 ).3خييت | ً ً  0.2اىخثشيِ (
ت ٍعْىيا ٍقاسّت بَجَىعت راد حشميض اىعظاسة اىظفشاويت اىنييت في اىَجَىعاث اىَذسوس
مَا ىٌ حظهش اىَعاىٌ اىنيَىحيىيت اىخي حٌ قياسها ( اىبشوحيِ اىنيي، اىضلاه ،حَض اىبىه)  اىشاهذ.
 فشوقاث ٍعْىيت في اىَجَىعاث اىَذسوست.
 IIX
 
خيظج اىذساست اىي اُ عىص خلايا اىخثشيِ يشحبظ  ٍع ّقظاُ ّشاط الاّضيٌ جيىحاثيىُ 
 َاىىُ داي اىذيهايذ في خلايا اىخثشيِ ىَشضي اىَلاسيا.بيشومسيذيض وصيادة حشميض اى
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1. Introduction and literature review 
 
 
1.1. Introduction:-  
 
Malaria is a parasitic disease caused by the sporozoan protozoa plasmodium. 
It remains one of the most prevalent and serious diseases in the world. The 
endemic transmission occurs in about 120 countries; which together represent 
more than one half of the world population (WHO, 2002). 
 
Malaria is transmitted to humans and animals by the bite of infected female 
anopheles mosquitos. Malaria is a very serious clinical problem as it affects 
normal growth, health and may cause many biochemical alterations in the 
blood, as it causes hypoglycemia and subclinical convulsion (Silamut et al., 
1999).   In tropical areas, malaria is one of the major causes of morbidity and 
mortality for children and women (Brian et al., 2005).  
 
Snow et al (2005) reported that the epidemiology of malaria in adults who live 
in malaria endemic areas is a neglected area of research. Malaria control 
strategies have focused on children under the age of 5 years and pregnant 
women, as the majority of malaria-related sickness and death is seen in these 
two groups. However, early studies in West Africa showed that clinical 
attacks of malaria also occur in adults living in areas of high endemicity 
(Miller, 1958). Recent report points out the considerable contribution of 
malaria as a cause of death in adults (Adjuik et al., 2006). 
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Acute malaria is often associated with mild or moderate thrombocytopenia in 
non-immune adults and children in malaria endemic areas and is a sensitive 
but non-specific indicator of infection with malaria parasites. Profound 
thrombocytopenia is unusual, and thrombocytopenia is rarely associated with 
hemorrhagic manifestations or a component of disseminated intravascular 
coagulation either in non-immune adults or children in endemic areas (Kelton 
et al., 1983) (Wickramasinghe and Abdalla,  2000). 
 
Reactive oxygen (ROS) or nitrogen species (RNS) are considered to play 
diverse roles in many aspects of physiological and pathological events 
(Akaike and Maeda,  2000). Oxidative stress can be measured in biological 
fluids by analysis of endogenous products of lipid peroxidation such as 
malondialdehyde (MDA) or by measurement of enzymes involved in 
antioxidant mechanisms.  
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1.2. Literature review: 
 
1.2.1. Malaria etiology and life cycle: 
 
Malaria is caused by obligate intra-erythrocytic protozoa of the genus 
Plasmodium. Humans can be infected with one (or more) of the following five 
species: Plasmodium falciparum, P. vivax, P. ovale, P. malariae and P. 
knowlesi. Plasmodia are primarily transmitted by the bite of an infected 
female Anopheles mosquito, but infections can also occur through exposure to 
infected blood products (transfusion malaria) and by congenital transmission. 
Among the five species, P. falciparum is the predominant one in Sudan, and is 
responsible for most of malaria-related morbidity and mortality (Brian et al., 
2005).  
 
When the infected anopheline mosquito takes a blood meal, sporozoites are 
inoculated into the bloodstream as shown in:  Figure (1- 1). Within 2-30 
minutes sporozoites enter hepatocytes and begin to divide into exo-
erythrocytic merozoites (tissue schizogony). For P. vivax and P. ovale, 
dormant forms called hypnozoites may typically remain quiescent in the liver 
until a later time; P. falciparum does not produce hypnozoites. Once 
merozoites leave the liver, they invade erythrocytes and develop into early 
trophozoites, which are ring shaped, vacuolated and uninucleated. Once the 
parasite begins to divide, the trophozoites are called schizonts, consisting of 
many daughter merozoites (blood schizogony). Eventually, the infected 
erythrocytes are ruptured, releasing merozoites, which subsequently invade 
other erythrocytes, starting a new cycle of schizogony. The duration of each 
cycle in P. falciparum is about 48 hours. In non-immune humans, the 
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infection is amplified about 20-fold each cycle. After several cycles, some of 
the merozoites develop into gametocytes, the sexual stages of malaria, which 
cause no symptoms, but are infective for mosquitoes (Garcia, 2001).Within 
the mosquito gut, zygotes are formed, which develop further and eventually 
become sporozoites that reside in the salivary glands. These sporozoites are 
released into the blood stream of a new human victim when the female 
mosquito takes the blood meal. 
 
1.2.2. Malaria symptoms: 
 
Symptoms of malaria include fever, shivering, arthralgia (joint pain), 
vomiting, anemia (caused by hemolysis), hemoglobinuria, and convulsions. 
There may be the feeling of tingling in the skin, particularly with malaria 
caused by P. falciparum. The classical symptom of malaria is cyclical 
occurrence of sudden coldness followed by rigor and then fever and sweating 
lasting four to six hours, occurring every two days in P. vivax and P. ovale 
infections, while every three days for P. malariae (Aikawa,1988).   
 
P. falciparum can have recurrent fever every 36-48 hours or a less pronounced 
and almost continuous fever. For reasons that are poorly understood, but 
which may be related to high intracranial pressure, children with malaria 
frequently exhibit abnormal posturing, a sign indicating severe brain damage 
(Idro et al., 2007).
 
 Malaria has been found to cause cognitive impairments, 
especially in children. It causes widespread anemia during a period of rapid 
brain development and also direct brain damage. This neurologic damage 
results from cerebral malaria to which children are more vulnerable (Boivin, 
2002).  
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Figure (1-1): the life cycle of P. falciparum in human host and mosquito 
vector. 
Adopted by: (WHO, 2007) 
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Figure (1- 2): the symptoms of malaria 
Adopted by :( http://www.webmd.com) 
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1.2.3.  Malaria pathogenesis and complications: 
 
Pathogenesis relates to the various host and parasite factors that are 
responsible for causing pathology. The pathogenic process occurs only during 
the erythrocytic cycle. During this stage, there is a huge, periodic 
amplification of the size of parasite populations that may enhance the 
probability of differentiation to gametocytes, the stage infectious to 
mosquitoes. A peculiarity of P. falciparum is its ability to adhere to venular 
endothelium (cytoadherence) of erythrocytes infected with maturing parasites. 
The parasitized erythrocytes remain attached until merozoites are formed that 
are released to invade other erythrocytes.   Thus, the predominant form seen in 
the peripheral circulation is the ring-infected erythrocyte, the young form of 
the parasite (Louis et al., 1994). 
 
Malaria in humans develops via two phases:  
I. An exoerythrocytic (hepatic) and an  
II. Erythrocytic phase.  
 
When an infected mosquito pierces a person's skin to take a blood meal, 
sporozoites in the mosquito's saliva enter the bloodstream and migrate to the 
liver. Within 30 minutes of being introduced into the human host, they infect 
hepatocytes, multiplying asexually and asymptomatically for a period of 6–15 
days. Once in the liver these organisms differentiate to yield thousands of 
merozoites which, following rupture of their host cells, escape into the blood 
and infect red blood cells, thus beginning the erythrocytic stage of the life 
cycle (Bledsoe 2005). The parasite escapes from the liver undetected by 
wrapping itself in the cell membrane of the infected host liver cell (Sturm et al 
.,2006). 
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Within the red blood cells the parasites multiply further, again asexually, 
periodically breaking out of their hosts to invade fresh red blood cells. Several 
such amplification cycles occur. Thus, classical descriptions of waves of fever 
arise from simultaneous waves of merozoites escaping and infecting red blood 
cells (Aikawa, 1988).  
Some P. vivax and P. ovale sporozoites do not immediately develop into 
exoerythrocytic-phase merozoites, but instead produce hypnozoites that 
remain dormant for periods ranging from several months (6–12 months is 
typical) to as long as three years. After a period of dormancy, they reactivate 
and produce merozoites. Hypnozoites are responsible for long incubation and 
late relapses in these two species of malaria (Cogswell, 1992).
  
 
The parasite is relatively protected from attack by the body's immune system 
because for most of its human life cycle it resides within the liver and blood 
cells and is relatively invisible to immune surveillance. However, circulating 
infected blood cells are destroyed in the spleen. To avoid this fate, the P. 
falciparum parasite displays adhesive proteins on the surface of the infected 
blood cells, causing the blood cells to stick to the walls of small blood vessels, 
thereby sequestering the parasite from passage through the general circulation 
and the spleen (Chen et al., 2000). This "stickiness" is the main factor giving 
rise to hemorrhagic complications of malaria. High endothelial venules (the 
smallest branches of the circulatory system) can be blocked by the attachment 
of masses of these infected red blood cells. The blockage of these vessels 
causes symptoms such as in placental and cerebral malaria. In cerebral malaria 
the sequestrated red blood cells can breach the blood brain barrier possibly 
leading to coma (Adams et al., 2002).
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Some merozoites turn into male and female gametocytes. If a mosquito 
pierces the skin of an infected person, it potentially picks up gametocytes 
within the blood. Fertilization and sexual recombination of the parasite occurs 
in the mosquito's gut, thereby defining the mosquito as the definitive host of 
the disease. New sporozoites develop and travel to the mosquito's salivary 
gland, completing the cycle. Pregnant women are especially attractive to the 
mosquitoes (Lindsay et al., 2000), and malaria in pregnant women is an 
important cause of stillbirths, infant mortality and low birth weight (Van 
Geertruyden et al., 2004), particularly in P. falciparum infection, but also in 
other species infection, such as P. vivax (Rodriguez et al., 2006). 
 
 Most complications attacking African children are severe anaemia and 
cerebral malaria, but respiratory distress is the most dangerous (Schellenberg 
et al., 1990). 
 
Severe malarial anaemia also consists of a group of conditions with different 
causes, including direct destruction of parasitized red blood cells, indirect 
destruction of non-parasitized red blood cells by immune mechanisms, and 
bone-marrow suppression associated with imbalances in cytokine 
concentrations (Ekvall, 2003). 
 
As a prelude to later sections on malaria pathogenesis, it is helpful to consider 
the multifaceted nature of the interaction between the host immune system 
and the parasite. Central to this interaction are cytokines that are released by 
immunocompetent cells in a highly regulated fashion. They participate in the 
control of all immunologically relevant events, whether they concern either 
activation, proliferation, or subsequent effector functions of recirculating 
immunocompetent cells or regulation of cells residing in tissues (Lyke et al., 
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2004). It has been established that cytokines not only participate in the 
qualitative (antibody isotype switch) and quantitative regulation of the 
immune response but also participate in many other complex processes such 
as hematopoiesis and pregnancy. During the erythrocytic cycle, soluble 
products of Plasmodium spp. known as malarial toxins direct systemic release 
of proinflammatory cytokines [for example, tumor necrosis factor- α (TNF- α) 
which act on many other cellular systems such as endothelium.  
 
Equally important are parasite antigens, which stimulate T cells to directly 
secrete or induce production of cytokines from other cells. Before P. 
falciparum infection, many individuals have P. falciparum reactive T cells, 
often at high frequency. Such parasite-reactive T cells have probably arisen as 
a result of antigenic cross reactivity between environmental organisms and 
parasite-derived molecules (Currier et al., 1992).  
 
 
The parasite also has other strategies for interacting with the immune system, 
including the following: 
(i) Antigenic variation. 
(ii) A still undefined, splenic dependent regulation of parasite genes 
encoding structural proteins and adhesive molecules on the 
erythrocyte surface that are involved in adherence to endothelium. 
(iii) Low immunogenicity of conserved parasite peptides that are 
targets of antibodies able to interfere with parasite survival. 
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1.2.4.  Malaria diagnosis:-  
 
The most economic, preferred, and reliable diagnosis of malaria is 
microscopic examination of blood films because each of the four major 
parasite species has distinguishing characteristics. Two sorts of blood film are 
traditionally used. Thin films are similar to usual blood films and allow 
species identification. Thick films allow the microscopist to screen a larger 
volume of blood (Warhurst and Williams, 1996). 
In areas where microscopy is not available, or where laboratory staff are not 
experienced at malaria diagnosis, there are antigen detection tests that require 
only a drop of blood (Pattanasin et al., 2003).  
 
 
 
Figure (1-3): Ring stage of P. Falciparum 
Adopted by: (Cheesbrough, 2006) 
Molecular methods are available in some clinical laboratories and rapid real-
time assays (for example, QT-NASBA based on the polymerase chain 
reaction) (Mens et al., 2006) are being developed with the hope of being able 
to deploy them in endemic areas. 
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Thrombocytopenia:  
 
Platelets, or thrombocytes are small, irregularly-shaped a nuclear cells (i.e. 
cells that do not have a nucleus containing DNA), 2-3 µm in diameter 
(Campbell, 2008), which are derived from fragmentation of precursor 
megakaryocytes.  The average lifespan of a platelet is between 8 and 12 days. 
Platelets play a fundamental role in hemostasis and are a natural source of 
growth factors. They circulate in the blood of mammals and are involved in 
hemostasis, leading to the formation of blood clots (Campbell, 2008). 
 
 
 
Figure (1- 4): platelets picture stained by Giemsa stain 
Adopted by (cheesbrough, 2006) 
 
When the number of platelets is too low, excessive bleeding can occur. 
However, if the number of platelets is too high, blood clots can form 
(thrombosis), which may obstruct blood vessels and result in such events as a 
stroke, heart attack, pulmonary embolism or the blockage of blood vessels to 
other parts of the body, such as the extremities of the arms or legs.  An 
abnormality or disease of the platelets is called a thrombocytopathy (Maton et 
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al.,1993), which could be either a low number of platelets 
(thrombocytopenia), a decrease in function (thrombasthenia), or an increases 
in their number (thrombocytosis). There are disorders that reduce the number 
of platelets, such as heparin-induced thrombocytopenia (HIT) or thrombotic 
thrombocytopenic purpura (TTP) that typically causes thromboses, or clots, 
instead of bleeding (Kumar and Clark 2005). 
 
  Generally speaking, in humans, a normal platelet count ranges from 150,000 
and 450,000 per mm
3
.  These limits, however, are determined by the 2.5th 
lower and upper percentile, and a deviation does not necessarily imply any 
form of disease (Correia et al., 2008) and (Cheung et al., 2005).  
 
1.2.5.  Thrombocytopenia and Malaria: 
 
 In most clinical studies, thrombocytopenia is associated neither with the 
severity of disease or death in malaria. Nevertheless, platelets have been 
implicated in animal, clinical and experimental studies of malaria 
pathogenesis. Platelets mediate a syndrome of cerebral malaria in an animal 
model of malaria infection (Van et al., 2005).  
 
 Histopathological studies of children who have died of severe malaria 
showed that platelet clumps with and without infected erythrocytes are 
frequently found in the vasculature (Grau et al., 2005). Also infected 
erythrocytes may adhere to platelets, and the clumps of infected erythrocytes 
and platelets have been associated with severe disease (Pain et al., 2001). 
Therefore, there remains a paradox that, while thrombocytopenia is associated 
with infection and platelets have been implicated in the pathogenesis of severe 
disease, most studies suggest that low counts of platelets are not associated 
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with an adverse outcome (Ladhani et al., 2002) (Newton et al., 2004).Without 
understanding this paradox, it is not possible to evaluate the true contribution 
of platelet to the pathogenesis of severe malaria. The causes of 
thrombocytopenia in acute malaria are poorly understood. Certainly, increased 
platelet destruction is significant during malaria infection. The platelet 
lifespan is reduced during malaria (Kreil et al., 2000), which seems to be 
associated with a diffuse pattern of platelet sequestration rather than a 
predominant splenic or hepatic clearance (Karanikas et al., 2004). 
Thrombocytopenia is often associated with palpable splenomegaly (Kueh and 
Yeo, 1982) and circulating immune complexes. The contribution of 
abnormalities of platelet production to thrombocytopenia during malaria 
infection is less clear. Early studies in malaria patients described dysmorphic 
megakaryocytes in the bone marrow of patients with acute falciparum malaria 
(Knuttgen, 1987). Other investigators showed less lobulated and immature 
megakaryocytes in Gambian children with acute malaria (Abdalla, 1990).  
Moreover, the biosynthesis and regulation of thrombopoietin (TPO), the main 
growth factor for megakaryocytes and thrombocytopoiesis, seems to be 
normal in patients with malaria (Kreil et al., 2000).  
 
1.2.6. Oxidative Stress: 
 
Free radicals Reactive Oxygen Species (ROS) and   Reactive Nitrogen 
Species (RNS) are considered to play significant and various roles in many 
aspects of physiological and pathological events .When pro-oxidants increase 
or antioxidants fall, Oxidative Stress (OS) ensues that leads to excessive 
molecular damage and tissue injury (Januel et al., 2006). However, OS has 
been defined as an imbalance of increased oxidants and decreased 
antioxidants. During metabolism, aerobic organisms form ROS, such as anion 
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radical superoxide (O2 
•‾
), hydrogen peroxide (H2O2), hypochlorous acid, 
hydroxyl (
•
OH), hydroperoxyl or RNS such as nitric oxide (NO
•
), nitrogen 
dioxide radical and anion peroxynitrite. These free radicals are constantly 
produced during normal aerobic metabolism and are safely removed by a 
variety of biological endogenous and exogenous antioxidants (Gutteridge, 
1995).  
 
Malondialdehyde (MDA) is an endogenous aldehyde produced by fatty acid 
oxidation and has been used as marker of OS. Glutathione peroxidase (GPx) is 
a selenium- dependent and lipid peroxide-scavenging enzyme that effectively 
reduces lipid peroxides with the concomitant oxidation of glutathione. Its 
activity can be altered under OS conditions (Gutteridge, 1995). 
Activated phagocytes produce ROS and RNS that help to kill some types of 
microorganisms. However, the method by which these species destroy 
microorganisms’ remain unclear; both direct oxidative damage and indirect 
damage (whereby reactive species promote the actions of other antibacterial 
agents) are involved, and no single mechanism is likely to account for the 
killing of all microorganisms. Neutrophils, monocytes, eosinophils and 
macrophages respond to appropriate stimuli by a marked increase in O2 
uptake, termed the respiratory burst (Halliwell, 2006). 
 
The presence of OS during malaria infection is already known, although not 
totally understood. Either a protective or deleterious role of this OS seems to 
occur in patients with malaria (Pabón et al., 2003). Malarial infection induces 
the generation of 
•
OH radical in the liver, which may be responsible for the 
induction of OS and apoptosis (Guba et al., 2006). NO
•
 is a molecule that has 
been proposed to have a crucial role in malaria pathogenesis (Sobolewscki et 
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al., 2005). The malaria parasite itself is reported to generate large quantities of 
H2O2 and O2 (Hunt and Stocker, 1990), (Mishra et al., 1994). 
The mechanism of thrombocytopenia in malaria is not clearly known and OS 
may play a role in this process. ROS species may have important functions in 
the structural and functional alterations of platelets and in the mechanism of 
thrombocytopenia in malaria (Erel et al., 2001). 
 
1.2.7. Glutathione peroxidase (GPx): 
 
Glutathione peroxidase (EC 1.11.1.9) was discovered in 1957 by Gordon C. 
Mills (Mills. 1957). It is the general name of an enzyme family with 
peroxidase activity whose main biological role is to protect the organism from 
oxidative damage. The biochemical function of glutathione peroxidase is to 
reduce lipid hydroperoxides to their corresponding alcohols and to reduce free 
hydrogen peroxide to water. 
Reaction: 
 
An example reaction that glutathione peroxidase catalyzes is: 
2GSH + H2O2 → GS–SG + 2H2O, 
Where GSH represents reduced monomeric glutathione, and GS–SG 
represents glutathione disulfide. 
 
Glutathione reductase then reduces the oxidized glutathione to complete the 
cycle (Valentinaet al., 2009): 
GS–SG + NADPH + H+ → 2 GSH + NADP+. 
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Reaction mechanism: 
 
The mechanism is at the Selenocystein site, which is in a Se (-) form as resting 
state. This is oxidized by the peroxide to SeOH which is then trapped by a 
GSH molecule to Se-SG and by another GSH molecule to Se (-) again, 
releasing a GS-SG by-product (Forstrom et al., 1978) and (Ceballos-Picot et 
al., 1992). 
 
Structure: 
 
Mammalian GPx1, GPx2, GPx3, and GPx4 have been shown to be selenium-
containing enzymes, whereas GPx6 is a selenoprotein in humans with 
cysteine-containing homologues in rodents. GPx1, GPx2, and GPx3 are 
homotetrameric proteins, whereas GPx4 has a monomeric structure. As the 
integrity of the cellular and subcellular membranes depends heavily on 
glutathione peroxidase, the antioxidative protective system of glutathione 
peroxidase itself depends heavily on the presence of selenium (Muller et al., 
2007). 
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1.2.8. Uric acid: 
 
Uric acid is produced by xanthine oxidase from xanthine and hypoxanthine, 
which in turn are produced from purine. Uric acid is more toxic to tissues than 
either xanthine or hypoxanthine. Uric acid is released in hypoxic conditions 
(Baillie et al., 2007).  
In humans and higher primates, uric acid is the final oxidation (breakdown) 
product of purine metabolism and is excreted in urine. In most other 
mammals, the enzyme uricase further oxidizes uric acid to allantoin (Angstadt 
and Carol, 1997). The loss of uricase in higher primates parallels the similar 
loss of the ability to synthesize ascorbic acid (Proctor, 1970). Both uric acid 
and ascorbic acid are strong reducing agents (electron donors) and potent 
antioxidants. In humans, over half the antioxidant capacity of blood plasma 
comes from uric acid (Baillie et al., 2007).  In humans, about 70% of daily 
uric acid disposal occurs via the kidneys, and in 5-25% of humans impaired 
renal (kidney) excretion leads to hyperuricemia (Vitart et al., 2008). 
 
Uric acid may be a marker of oxidative stress (Becker, 1993), and may have a 
potential therapeutic role as an antioxidant (Glantzounis et al., 2005). On the 
other hand, like other strong reducing substances such as ascorbate, uric acid 
can also act as a prooxidant (Proctor, 1972), particularly at elevated levels. 
Thus, it is unclear whether elevated levels of uric acid in diseases associated 
with oxidative stress such as stroke and atherosclerosis are a protective 
response or a primary cause (Proctor, 2008). For example, some researchers 
propose that hyperuricemia-induced oxidative stress is a cause of metabolic 
syndrome (Hayden and Tyagi, 2004). On the other hand, plasma uric acid 
levels correlate with longevity in primates and other mammals (Cutler, 1984). 
This is presumably a function of urate's antioxidant properties. 
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Uric acid is the most abundant aqueous antioxidant in humans, and contributes
 
as much as two-thirds of all free radical scavenging capacity
 
in plasma. It is 
particularly effective in quenching hydroxyl,
 
superoxide and peroxynitrite 
radicals, and may serve a protective
 
physiological role by preventing lipid 
peroxidation (Squadrito et al., 2000).In a
 
variety of organs and vascular beds, 
local uric acid concentrations
 
increase during acute oxidative stress and 
ischaemia, and the
 
increased concentrations might be a compensatory 
mechanism that
 
confers protection against increased free radical activity 
(Nieto et al., 2000).
 
In animal models, local uric acid  concentrations 
significantly increase
 
in acute brain injury(Tayag , 1996).For example, in the 
rat,
 
middle cerebral artery occlusion causes a significant increase
 
in cerebral 
uric acid  concentrations, which can persist for several
 
days after the 
injury(Kanemitsu, 1988). These observations have prompted interest
 
in the 
potential impact of raised local uric acid concentrations in
 
the setting of acute 
ischaemic stroke. 
 
1.2.9. Bilirubin: 
 
Bilirubin (formerly referred to as hematoidin) is the yellow breakdown 
product of normal heme catabolism. Heme is found in hemoglobin, a 
principal component of red blood cells. Bilirubin is excreted in bile and urine 
(Chang et al., 2007), and elevated levels may indicate certain diseases. It is 
responsible for the yellow color of bruises, urine, and the yellow 
discoloration in jaundice. 
 
Bilirubin consists of an open chain of four pyrrole-like rings (tetrapyrrole). In 
heme, by contrast, these four rings are connected into a larger ring, called a 
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porphyrin ring. Some of the double-bonds in bilirubin isomerize when 
exposed to light. This is used in the phototherapy of jaundiced newborns: the 
isomer of bilirubin formed upon light exposure is more soluble than the 
unilluminated isomer. 
 
Bilirubin is created by the activity of biliverdin reductase on biliverdin, a 
green tetrapyrrolic bile pigment which is also a product of heme catabolism. 
Bilirubin, when oxidized, reverts to become biliverdin once again. This 
cycle, in addition to the demonstration of the potent antioxidant activity of 
bilirubin, has led to the hypothesis that bilirubin's main physiologic role is as 
a cellular antioxidant (Baranano et al., 2002).  
 
1.2.10. Total plasma protein: 
 
Also called serum proteins, are proteins found in blood plasma. Serum total 
protein in blood is 7g/dl, which in total makes 7% of total blood volume. They 
serve many different functions, including: 
1. Circulatory transport molecules for lipids, hormones, vitamins 
and metals. 
2. Enzymes complement components, protease inhibitors, and kinin 
precursors. 
3. Regulation of a cellular activity and functioning and in the 
immune system. 
 
All the plasma proteins are synthesized in liver except gamma globulins. 60% 
of plasma proteins are made up of the protein albumin, which are major 
contributors to osmotic pressure of plasma which assists in the transport of 
lipids and steroid hormones. Globulins make up 35% of plasma proteins and 
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are used in the transport of ions, hormones and lipids assisting in immune 
function. 4% is fibrinogen which is essential in the clotting of blood and can 
be converted into insoluble fibrin. Regulatory proteins which make up less 
than 1% of plasma proteins are proteins such as enzymes, proenzymes and 
hormones. Current research regarding blood plasma proteins is centered on 
performing proteomics analyses of serum/plasma in the search for 
biomarkers. These efforts started with two-dimensional gel electrophoresis 
(Anderson and Anderson, 1977). 
 
The total thiol status in the body, especially thiol (-SH) groups present on 
protein are considered as major plasma antioxidants in vivo and most of the 
SH-groups are present over albumin and are major reducing groups present in 
our body fluids. (Himmelfarb et al., 2000)],( Himmelfarb and McMongale, 
2001).Ceruloplasmin (CP) is an alpha-2, acute phase-responsive, multicopper 
oxidase glycoprotein that contains>95% of the copper present in plasma. 
Antioxidant activity of CP can be ascribed mainly to its ferroxidase activity, 
which inhibits ferrous ion-stimulated lipid peroxidation and the formation of 
hydroxyl radicals in the Fenton reaction, and is also a scavenger of ROS 
(Osaki et a., 1966) and (Cunningham et al., 1995). 
1.2.11. Plasma Albumin: 
 
Serum albumin is the most abundant blood plasma protein and is produced in 
the liver and forms a large proportion of all plasma protein. It  normally 
constitutes about 60% of human plasma protein. Serum albumins are 
important in regulating blood volume by maintaining the oncotic pressure 
(also known as colloid osmotic pressure) of the blood compartment. They also 
serve as carriers for molecules of low water solubility this way isolating their 
hydrophobic nature, including lipid soluble hormones, bile salts, unconjugated 
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bilirubin, free fatty acids (apoprotein), calcium, ions (transferrin), and some 
drugs like warfarin, phenobutazone, clofibrate & phenytoin. For this reason, 
it's sometimes referred as a molecular "taxi". Competition between drugs for 
albumin binding sites may cause drug interaction by increasing the free 
fraction of one of the drugs, thereby affecting potency. Low albumin 
(hypoalbuminemia) may be caused by liver disease, nephrotic syndrome, 
burns, protein-losing enteropathy, malabsorption, malnutrition, late 
pregnancy, artefact, genetic variations and malignancy (Ballmer, 2001). 
 
High albumin (hyperalbuminemia) is almost always caused by dehydration. 
In some cases of retinol (Vitamin A) deficiency the albumin level can 
become raised to High-normal values. This is because retinol causes cells to 
swell with water (this is also the reason too much Vitamin A is toxic) (Gaull, 
1986). In lab experiments it has been shown that All-trans retinoic acid down 
regulates human albumin production (Suzuki, 2006). 
 
1.2.12. Red blood cells: 
 
Red blood cells (also referred to as erythrocytes) are the most common type 
of blood cell and the vertebrate organism's principal means of 
delivering oxygen (O2) to the body tissues via the blood flow through 
the circulatory system. A typical human erythrocyte has a disk diameter of 6–
8 µm and a thickness of 2 µm, being much smaller than most other human 
cells. Women have about 4 to 5 million erythrocytes per microliter (cubic 
millimeter) of blood and men about 5 to 6 million. Human red blood cells 
take on average 20 seconds to complete one cycle of circulation (Hillman et 
al., 2005).  As red blood cells contain no nucleus, protein biosynthesis is 
currently assumed to be absent in these cells, although a recent study 
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indicates the presence of all the necessary biomachinery in human red blood 
cells for protein biosynthesis (Kabanova et al., 2009).  
The blood's red color is due to the spectral properties of 
the hemic iron ions in hemoglobin. Each human red blood cell contains 
approximately 270 million of these hemoglobin biomolecules, each carrying 
four heme groups; hemoglobin comprises about a third of the total cell 
volume. This protein is responsible for the transport of more than 98% of the 
oxygen (the remaining oxygen is carried dissolved in the blood plasma). The 
red blood cells of an average adult human male store collectively about 2.5 
grams of iron, representing about 65% of the total iron contained in the body 
(Kenneth, 2007).  
 
1.2.13. White blood cells: 
 
White blood cells (WBCs), or leukocytes, are cells of the immune system 
involved in defending the body against both infectious disease and foreign 
materials. Five (LaFleur, 2008) different and diverse types of leukocytes 
exist, but they are all produced and derived from a multipotent cell in the 
bone marrow known as a hematopoietic stem cell. Leukocytes are found 
throughout the body, including the blood and lymphatic system.  
The number of WBCs in the blood is often an indicator of disease. There are 
normally between 4×10
9
 and 1.1×10
10
 white blood cells in a liter of blood, 
making up approximately 1% of blood in a healthy adult (Alberts, 2005). An 
increase in the number of leukocytes over the upper limits is called 
leukocytosis, and a decrease below the lower limit is called leukopenia. The 
physical properties of leukocytes, such as volume, conductivity, and 
granularity, may change due to activation, the presence of immature cells, or 
the presence of malignant leukocytes in leukemia. There are several different 
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types of white blood cells. They all have many things in common, but are all 
distinct in form and function. A major distinguishing feature of some 
leukocytes is the presence of granules; white blood cells are often 
characterized as granulocytes or agranulocytes. 
 
Granulocytes (polymorphonuclear leukocytes):  
 
Leukocytes characterized by the presence of differently staining granules in 
their cytoplasm when viewed under light microscopy. These granules are 
membrane-bound enzymes which primarily act in the digestion of 
endocytosed particles. There are three types of granulocytes: neutrophils, 
basophils, and eosinophils, which are named according to their staining 
properties (Witko-Sarsat, et al., 2000). 
 
Agranulocytes (mononuclear leucocytes):  
 
Leukocytes characterized by the apparent absence of granules in their 
cytoplasm. Although the name implies a lack of granules these cells do 
contain non-specific azurophilic granules, which are lysosomes (Gartner and 
Hiatt, 2007) the cells include lymphocytes, monocytes, and macrophages. 
 
Due to scare of information that relates the thrombocytopenia and oxidative 
stress in Sudan, therefore, this study aim to investigate the role of oxidative 
stress and some antioxidant markers in Sudanese patients with malaria 
infection.  
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1.3. Objectives: 
 
1.3.1 General objective: 
 
To investigate oxidative stress and antioxidant status in thrombocytopenia 
mediated by Plasmodium falciparum malaria. 
 
1.3.2 Specific objectives: 
 
1. To assay the activity of the enzyme glutathione peroxidase in 
platelets. 
2.  To evaluate the level of Malondialdehyde in platelets.    
3. To measure the plasma level of total protein and albumin. 
4. To measure the level of plasma uric acid. 
5. To measure the level of plasma total and conjugated bilirubin 
in thrombocytopenic and non cytopenic malaria patients. 
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2. Materials and methods: 
 
2.1   Subjects: 
Forty patients with malaria participated in this study; twelve were male and 
twenty eight female, their ages ranged between (2- 75 years). They were 
admitted to Sennar Teaching Hospital. The patients were confirmed to have 
malaria through blood film examination and ten healthy individuals from 
Sennar area were selected as control group. 
 
2.2 Instruments: 
 
 Microscope (Olumpus). 
  U.V Spectrophotometer (P-D303S). 
 Sysmex hematology analyzer (ORPHEE company; 
Switzerland, Id: 102405-000639).  
 Bench centrifuge. 
 Glassware. 
 Water bath. 
 
2.3 Chemicals and reagents: 
 
The glutathione peroxidase kit and malondialdehyde kit were produced by 
Biodiagnostic Company (Giza - Egypt) and the total protein, albumin, uric 
acid, conjugated and un conjugated bilirubin kits were produced by 
Biosystems S.A. Company (Barcelona – Spain). 
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Reagents storage:  
All reagents and standards were stored in refrigerator at 15 °C. 
 
2.3.1. Giemsa stain: 
 
Giemsa stain was prepared by the standard method adopted by 
Cheesbrough (2006). 
 
To prepare 500 ml of Giemsa stain: 
A. Giemsa powder . . . . . . . . . . . . . . . . . . . . . . . . 3.8 g. 
B. Glycerol (glycerin) . . . . . . . . . . . . . . . . . . . 250 ml. 
C. Methanol (methyl alcohol) . . . . . . . . . .. . . . 250 ml. 
 
        Preparation of Giemsa stain:          
 
1.  Giemsa powder was weighed, and transferred to a dry brown bottle 
of 500 ml capacity which contains a few dry glass beads. 
2. Using a dry measuring cylinder, 250 ml methanol were measured, and 
added to the stain and mixed well.  
3. Using the same cylinder, 250 ml glycerol was measured and added to 
the stain. The contents were mixed well. 
4. The bottle of stain was placed in a water bath at 60 °C for one hour to 
dissolve. It was mixed well at intervals till well mixed. 
5.   The bottle was labeled, and marked as flammable and toxic. It was 
stored at room temperature in the dark.  
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2.3.2. Glutathione peroxidase enzyme kits: 
 
Reagent 1 (R1):- 
 
Assay Buffer, pH 7.0 (Phosphate Buffer)                               50 mM.         
Triton X-100                                                                           0.1%.  
                
Reagent 2 (R2):- 
 
NADPH reagent (Lyopholized): 
Glutathione (GSH)                                                                      24µmol.  
Glutathione reductase                                                                    ≥ 12 U. 
 Nicotinamide- adenine dinucleotide phosphate reduced (NADPH)   4.8 µmol. 
Reagent 3 (R3):- 
Substrate (H2O2). 
Preparation of working reagents: 
 
Buffer reagent (R1): content ready for use. 
 The content in the vial R2 was reconstituted with 5 ml buffer 
R1, (stable for one week at -20ºC). 
 R3 was diluted 100 times immediately before used (0.1 ml of 
H2O2 + 9.9 ml DW). It was discarded after use. 
 
2.3.3. Malondialdehyde assaying kit: 
 
Malondialdehyde standard                                                       10 nmol/ml. 
Chromogen (Thiobarbituric acid, Detergent and stabilizer)     25 mmol/L. 
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2.3.4. Total protein estimation kits (Biuret reagent): 
 
Composition of the reagent:-  
 
A. Reagent: 
 Copper (II) acetate                                               6 mmol/L.  
 Potassium iodide                                                  12 mmol/L. 
  Sodium hydroxide                                               1.15mol/ L. 
 Detergent.  
B. Protein standard: 
             Bovine albumin                                                     8g/dl. 
 
2.3.5. Albumin estimation kit (bromocresol green reagent): 
 
Composition of the reagent:-  
 
A. Reagent:  
Acetate buffer                                                                           100ml/ L. 
 Bromocresol green                                                                   0.27 mmol/L. 
 Detergent, pH4.1. 
B. Albumin standard: 
 Bovine albumin                                                                        6g/dl. 
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2.3.6. Uric acid estimation kit: 
 
Composition of  the reagent:-  
A. Reagent: 
 Phosphate buffer (pH 7.5) –                                    50 mmol/l.  
 4- Aminoantipyrine -                                               0.3mmol/l. 
 3, 5, Dichloro-2- hydroxybenzenesulphonate –     4.0 mmol/l. 
 Uricase  -                                                                     200 U/l. 
 Peroxidase  -                                                            100 KU/l. 
 Stabilize, detergents and preservatives – 
B. Uric acid standard:                                                            8mg/dl. 
 
2.3.7. Total bilirubin estimation kit: 
 
Composition of  the reagent:-  
 
 AT reagent (reagent A):  
 sulfanilic acid                                                         29 mmol/L. 
  Hydrochloric acid                                                  0.2mol/L. 
  Cetrimide                                                               50mmol/L. 
 BT reagent (reagent B):  
 Sodium nitrite                                                         11.6mmol/L. 
 
 
 
31 
 
 Reagent preparation:-   
 
Working reagent: 
The content of BT reagent vial was transferred into AT reagent bottle and 
mixed thoroughly. 
 
2.3.8. Conjugated bilirubin Estimation kit (Diazotized sulfanilic reagent): 
 
Composition of the reagent:-  
 
 AD reagent (reagent A):  
 Sulfanilic acid                                                 35mmol/L. 
  Hydrochloric acid                                          0.24mol/L. 
 BD Reagent (reagent B):  
 Sodium nitrite                                                 3.5mmol/L. 
  Reagent preparation:-   
 
 Working reagent: 
 
The content of BD reagent vial was transferred into AD reagent 
bottle and mixed thoroughly. 
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2.4. Collection of blood samples:- 
 
Blood samples were collected by finger puncture technique to prepare thick 
and thin blood film (BF) for malaria investigation. Before any treatment 5 ml 
of venous blood were collected and transferred into Ethylene Diamine Tetra 
Acetic acid dipotassium salts (K2 (EDTA)) test tubes and divided into two 
equal volumes, one was used for measuring the hematological parameters and 
platelets separation for assay the activity of platelet enzyme glutathione 
peroxidase and concentration of malondialdehyde. The other portion was 
centrifuged and plasma was separated, the plasma was used to measure the 
level of total protein, albumin, uric acid, total and conjugated bilirubin.    
. 
2.5. Malaria diagnosis: 
 
Patients were examined for malaria, Thick and thin blood films were 
prepared, stained with Giemsa stain and were examined for malaria parasite.  
The patients were confirmed to have plasmodium falciparum parasite.  
 
2.6. Assay of glutathione peroxidase activity: 
 
The glutathione peroxidase enzyme activity was measured according to the 
method adopted by Paglia and Valentine (1967). 
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1. Principle of the method:- 
 
 The assay is an indirect measure of the activity of cellular glutathione 
peroxidase (c-GPx).   
                                           c- GPx    
R-O-O-H + 2GSH  R-O-H + GSSG 
+H2O. 
                                         Glutathione reductase 
GSSG + NADPH +H 
+
  2GSH +NADP
+
. 
  
 
The oxidation of NADPH to NADP
+
 is accompanied by a decrease in 
absorbance at 340 nm (A340) providing a spectrophotometric means for 
measuring GPx enzyme activity.  
 
 
Platelets preparation for glutathione peroxidase and malondialdehyde:- 
 
 Platelets were prepared and lysed according to the method adopted by 
Claudio et al (2008). 
2 ml of blood were centrifuged at 500 rpm for 5 min to obtain platelet-rich 
plasma (PRP). The platelets were washed three times by centrifugation at 
2,000 rpm for 10 min. After each centrifugation, the supernatant was 
decanted and discarded, and the platelets pellet were resuspended into 500 
μL of a sodium chloride solution (0.89%) and immediately kept in 
refrigerator at 4ºC until the biochemical assays were performed. Platelet-poor 
plasma was separated from the remaining blood after the PRP separation by 
centrifugation at 3,500 rpm for 10 min. 
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2. Procedure:- 
 
One ml of reagent 1(R1) was taken into 10 ml test tube, 0.1 of reagent 2 (R2) 
was added, and then 0.1ml of sample was added. They were mixed well. 
Absorbance was measured twice: directly after mixing and after being 
allowed to stand for3 minutes at 340 nm/min against deionized water. 
 
3. Calculation:- 
 
I. The rate of decrease in absorbance (A340) per minutes was 
determined by calculating the difference in A340 nm between 60 and 
120 second. 
II. The net A340 nm /min for the sample was converted to NADPH 
consumed (nmol/min/ml) the following relationship were used. 
 1mU/ml = 1nmol/NADPH/min/ ml =   A340 /min 
                                                                  0.00622* 
 
III. The dilution of the sample was corrected: 
 Dilution of the sample prior to adding to the cuvate. 
 Dilution in the assay. 
= Total volume       =   1.21    =    121. 
   Volume of sample       0.01  
IV. The unit of the activity was expressed in the original sample per 
liter or in relationship to the protein. 
Enzyme activity (U /L) = A340  /min   X 121. 
                                                0.00622 
(*Extinction coefficient) 
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2.7. Determination of malondialdehyde concentration: 
 
Malondialdehyde concentration was measured according to the method 
adopted by Ohkawa (1979).  
1. Principle:- 
 
Thiobarbituric acid (TBA) reacts with malondialdehyde 
(MDA) in acidic medium at temperature 95ºC for 30 min to 
form a complex product (pink colour) which can be measured 
colorimetrically. 
 
2. Procedure:- 
One ml of chromogen reagent was pipetted into three test tubes 
which were labeled as blank, sample and standard. 0.2 ml of 
sample was added to the sample test tube, and 0.2 ml of standard 
was added to standard tube.  
 
Contents of each tube were mixed well, the test tube was covered 
by glass bead, and it was heated in water bath at 95 ºC for 30 
min, and it was allowed to cool. Then 0.2ml of sample blank was 
added to blank tube.  
 
Contents of each tube were mixed well, and the absorbances of 
the samples (A sample) and standard were read against the blank 
and standard at 534nm. 
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3. Calculation:- 
Malondialdehyde in sample =    A sample        X 10        
nmol/l 
                                                                                A standard  
 
 
2.8. Measurement of total protein concentration: 
 
Total protein was measured colorimetrically by Biuret method 
described by Tietz (1986). 
 
1. Principle of the method:- 
 
 Protein in the sample reacts with copper (II) ion in alkaline 
medium forming a coloured complex that can be measured by 
colorimeter.  
 
2. Procedure: 
I. One ml reagent was pipetted into three test tubes which were 
labeled as blank, sample and standard. 0.02 ml of sample was 
added to the sample test tube, and 0.2 ml of standard was added to 
standard tube, 0.02 ml distilled water was added to blank test tube.  
 
II. Contents of each tube were mixed thoroughly and allowed to stand 
for 10 minutes at room temperature. 
III. The absorbances (Abs) of the standard and the sample were read in 
a colorimeter at 545 nm against the blank.    
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3. Calculation:- 
 
               The protein concentrations in the samples were 
calculated using the following general formula: 
            Total protein (g/dl) =      Abs sample     X   Concentration of standard. 
                                                    Abs standard   
 
2.9. Estimation  of albumin concentration: 
 
Albumin was measured by bromocresol green method (BCG) adopted 
by Young, (1995). 
 
1. Principle of the method:- 
 
Albumin in the sample reacts with bromocresol green in acid medium forming 
a coloured complex that can be measured by colorimeter. 
 
 Procedure: 
I. One ml reagent was pipetted into three test tubes which were 
labeled as blank, sample and standard. 0.02 ml of sample was 
added to the sample test tube, and 0.2 ml of standard was 
added to standard tube, 0.02 ml distilled water was added to 
blank test tube.  
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II. Contents of each tube were mixed thoroughly and allowed to 
stand for 10 minutes. 
 
III. The absorbances (Abs) of the standard and the samples were 
read in spectrophotometer at 545 nm against the blank.  
 
   
 
2. Calculation:- 
  The albumin concentration in the samples was calculated using 
the following general formula: 
          Albumin (g/dl)      =           Abs sample     X   Concentration of standard. 
                                                       Abs standard  
 
2.10.  Estimation of uric acid concentration: 
 
Uric acid was measured colorimetrically by (uricase/ PAP), the method 
adopted by Piero (2010).  
  
1. Principle of the method:- 
 
Uricase catalyzes the oxidation of uric acid to allantoin and H2O2. 
In the presence of peroxidase (POD), H2O2 react with 4- 
aminoantipyrine (4-AA) and 3, 5, dichloro-2-hydroxybenzenesulphonate 
(DHBS) to form a quinoneimine dye, the concentration of which at 
545nm is directly proportional to the uric acid concentration. 
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Uric acid +O2 + 2H2O –         uricase                        allantoin + 
CO2 + H2O2.  
  2 H2O2 + DHBS + 4AA -     POD                       Quinoneimine + 
4H2O. 
 
2. Procedure: 
 
I. One ml reagent was pipetted into three test tubes which were 
labeled as blank, sample and standard. 0.02 ml of sample was 
added to the sample test tube, and 0.2 ml of standard was 
added to standard tube, 0.02 ml distilled water was added to 
blank test tube.  
 
II. Contents of each tube were mixed thoroughly and incubated 
for 10 minutes at room temperature. 
 
III. The absorbances (Abs) of the standard and the samples were 
read in colorimeter at 545 nm against the blank.    
 
3. Calculation:- 
 
The uric acid concentration in the samples was calculated using the 
following general formula: 
             Uric acid (mg/dl)  =       Abs sample      X   Concentration of standard. 
                                                       Abs standard   
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2.11. Estimation of total bilirubin concentration: 
 
The total bilirubin was measured by Jendrassik and Grof, method adopted by 
Cheesbrough (2006). 
 
1.     Principle of the method:- 
 
 Bilirubin reacts with the diazotized sulphanilic acid (diazo reagent) 
to form azobilirubin. Caffeine is an accelerator and gives a rapid and 
complete conversion to azobilirubin. The pink colour of acidic 
azobilirubin is converted to blue azobilirubin by alkaline tartrate, 
which can be measured colourimetrically. 
 
2. Procedure: 
I. One ml working reagent was pipetted into three test tubes 
which were labeled as blank, sample and standard. Fourth test 
tube label sample blank containing 0.1ml sample and reagent 
(AD). 0.1 ml of sample was added to the sample test tube, and 
0.1 ml of standard was added to standard tube, 0.01 ml distilled 
water was added to blank test tube.    
 
II. Content of each tube were mixed thoroughly and allowed to 
stand for 2 minutes at room temperature. 
 
III. The absorbances (Abs) of the samples and blank were read in 
colorimeter at 540 nm against the distilled water.    
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IV. The absorbances (Abs) of the samples and of the standard were 
read against the reagent blank.  
 
 
3. Calculation:- 
 
                 The total bilirubin concentration in the samples was 
calculated using the following general formula: 
          Total bilirubin (mg/dl)   =    
                         Abs sample – Abs sample blank   X   Concentration of standard  
                                          Abs standard   
 
 
2.12.  Measurement of conjugated bilirubin concentration: 
 
The conjugated bilirubin was measured by Jendrassik and Grof, 
method adopted by Cheesbrough (2006). 
 
1. Principle of the method:- 
 
Direct bilirubin is measured as the total bilirubin method but in 
absence of the caffeine- benzoate catalyst and at an acid pH.  
Under these conditions only the conjugated bilirubin will react.  
 
2. Procedure: 
I. One ml working reagent was pipetted into three test tubes which 
were labeled as blank, sample and standard. Fourth test tube 
label sample blank containing 0.1ml sample and reagent (AD). 
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0.1 ml of sample was added to the sample test tube, and 0.1 ml of 
standard was added to standard tube, 0.01 ml distilled water was 
added to blank test tube.    
 
II. The contents of each tube were mixed thoroughly and allowed to 
stand for 2 minutes at room temperature. 
 
III. The absorbances (Abs) of the sample blank were read in 
colorimeter at 540 nm against the distilled water.    
 
IV. The absorbance (Abs) of the sample and of the standard were 
read against the reagent blank.  
 
 
3. Calculation:- 
 
                  The total bilirubin concentration in the sample was 
calculated using the following general formula: 
Conjugated bilirubin  (mg/dl) = 
                      Abs sample – Abs sample blank    X   Concentration of standard  
                                    Abs standard   
 
2.13. Hematological parameters: 
 
The hematological parameters measured in this study include: total white 
blood cell count (TWBCs), red blood cell count (RBCs), hemoglobin, 
mean cell volume (MCV), packed cell volume (PCV), mean cell 
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hemoglobin (MCH), mean cell hemoglobin concentration (MCHC), 
thrombocyte count and differential count of white blood cells. 
 
  These parameters were measured using the cell counter Mythic-18, 
(ORPHEE company; Switzerland, Id: 102405-000639), which uses multi-
techniques that can measure 18 blood parameters. 
 
Procedure: 
 
 One ml venous blood was put in the measuring device. 
Blood parameters were measured according to the following:  
 
A. Impedance :   
  
 Total erythrocyte count, total leukocyte count and the differential count 
were measured by the impedance method, in which blood cells can create 
electric resistance according to their diameter, which then can be detected 
by the galvanometer. 
 
B.  Colorimetric method: 
  
Hemoglobin was measured by colorimetric method. The method based 
on the conversion of the haemoglobin by means of drabkin's solution (0.2g 
potassium cyanide, 0.2 potassium ferricyanide, and 1g sodium bicarbonate 
per one liter of distilled water) to cyanomethaemoglobin concentration 
was measured by (cell counter Mythic-18) as g/dl of blood.     
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C. Centrifugation method: 
  
Mythic cell counter provided with a microhematocrit centrifuge to 
measure the (PCV) percentage within few seconds. 
 
D.  Calculation method: 
  
 Mean corpuscular volume (MCV), mean corpuscular hemoglobin 
(MCH) and Mean corpuscular hemoglobin concentration (MCHC), were 
then calculated from the RBC count, Hb and PCV.  
 
2.14.  Statistical analysis: 
 
Results of this study were statistically analyzed using (SPSS) program. 
Significant differences between groups were assessed by one-way ANOVA 
and t- test. Correlation matrix was done and the r values were obtained with 
level of significance. 
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3. Results 
 
 Data presented in the current study was obtained from a questionnaire and 
laboratory investigation of blood samples of Sudanese patients infected with 
malaria (40) and control group (10). 
 
3.1.Malaria infection and thrombocytopenia:- 
 
Blood film examination indicated that the 40 patients admitted to Sennar 
Teaching Hospital were infected with the parasite Plasmodium Falciparum. 
The distribution of respondents according to thrombocyte count (> 150.000) 
revealed that 10 (25%) of the malaria patients were thrombocytopenic and 30 
(75%) were without thrombocytopenia (Appendix I). 
 
Because of the obvious differences between malaria patients with 
thrombocytopenia (10) and those without thrombocytopenia (30), the study 
groups were classified into malaria with thrombocytopenia, malaria without 
thrombocytopenia and control groups. 
 
3.2.Activity of glutathione peroxidase:- 
 
Results presented in Table (1) and Figure (3-1) indicate that there was a 
significant difference (P >0.00) in the activity of glutathione peroxidase (GPx) 
between the studied groups, the highest enzyme activity was observed for the 
control group (1979 U/L) followed by malaria non thrombocytopenic (384 
U/L) and the least was the malaria thrombocytopenic group (112 U/L). 
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The activity of the enzyme GPx was almost similar for male and female 
malaria patients, but the females of the control group showed higher activity 
of GPx relative to that of the male group Figure (3-1). Results shown in 
Figure (3-2) indicate that the age group (18 -32 years) of the control group 
showed the highest activity of the enzyme GPx, compared to that of (2-18 
years) and (> 32 years) groups, which was almost similar. On the other hand 
the various age groups of the malaria patients showed slight differences in the 
enzyme activity. 
 
Results presented in Figure (3-3) and Table (2) indicated that the activity of 
the enzyme GPx was positively correlated with thrombocyte count(r = 0.602; 
P < 0.001), and it was negatively correlated with malondialdehyde (r = -0.36; 
P < 0.05) Figure (3-4). Whereas the activity of GPx enzyme was weakly 
correlated with total bilirubin, direct bilirubin, uric acid, total protein and 
albumin Table (2). 
 
3.3.Malondialdehyde: 
 
Results given in Table (1) indicated that TCP showed significantly higher (P> 
0.05) level of MDA (7.3 µmol/L) followed by NTCP (3.9 µmol/L) and the 
least was that of the control group (0.02 µmol/L). 
The concentration of MDA was negatively correlated with platelet count (r = -
0.696; P> 001). 
 
3.4.Hematological parameters: 
 
Results of the hematological parameters Red Blood Cells (RBCs),Hemoglobin 
(Hb), hematocrit (HCT), Mean Cell Volume (MCV), Mean Cell Hemoglobin 
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(MCH) and Mean Cell Hemoglobin Concentration(MCHC) presented in table 
(1) indicated that the difference in these parameters between studied group 
was not significant, except HCT which was significantly higher (P <0.005) in 
TCP (42.9%) relative to other groups (37.9%). The hematological parameter 
are weakly correlated to GPx, except MCV which was negatively correlated 
with GPx enzyme (r = -0.32; P<0.05). 
 
 
3.5.White blood cells and differential count: 
 
Results presented in Table (1) indicate that there was a significant difference 
(P >0.05) in TWBC between the studied groups, the highest TWBC was 
observed for the NTCP (7.9X10
3
 cell/cmm) followed by control (6.1X10
3
 
cell/cmm) and then the TCP group (5.1X10
3
 cell/cmm). 
 
3.6.Total and conjugated Bilirubin: 
 
  Results presented Table (1) show that the concentration of total bilirubin 
was slightly higher in blood of NCTP (0.7 mg/dl) and TCP (0.6 mg/dl) 
relative to that of the control group (0.47 mg/dl), whereas the level of 
conjugated bilirubin was almost similar for the studied groups. 
 
3.7.Uric acid concentration: 
 
Result presented in Table (1) showed that the concentration of uric acid in 
the plasma of the studied groups were similar. 
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3.8.Total protein and albumin: 
 
Data presented in Table (1) indicated that the concentration of total plasma 
protein was similar for all studied groups; likewise the level of plasma 
albumin was similar for various groups. 
 
  
Table (1 ): Some hematological parameters and markers of Oxidative stress in Non-
Thrombocytopenic, Thrombocytopenic malaria patients and healthy control group . 
 
No Parameter Malaria TCP Malaria NTCP  Control P value 
1 Glutathione peroxidase (U/L) 112.0 384.0 1979 0.0    
2 Malondialdehyde ( μmol/L) 7.3 3.9 0.0 0.0 
3 Uric acid (mg/dl) 5.8 5.5 5.6 0.37 
4 Total bilirubin (mg/dl) 0,6 0.7 0.4 0.01 
5 Direct bilirubin (mg/dl) 0.15 0.15 0.1 0.6 
6 Total protein (g/dl) 6.8 7.1 7.1 0.9 
7 Albumin (g/dl) 3.9 4.1 4.0 0.9 
8 TWBCs  (X10
3 
cell/cmm) 5.1 7.9 6.1 0.02 
9 RBCs (X10
6 
cell/cmm) 4.7 4.6 4.5 0.44 
10 Hb (g/dl) 13.9 12.7 12.5 0.09 
11 HCT (%) 42.9 37.9 37.9 0.08 
12 MCV (fL/cell) 91.1 82.3 85.2 0.04 
13 MCH (picograms/cell) 29.6 27.5 28.1 0.08 
14 MCHC (g/dl) 32.5 33.3 32.9 0.59 
15 Thrombocytes count X10
3 
cell/cmm 70.7 283.2 270.4 0.00 
16 Lymphocytes % 44.6 34.3 38.2 0.50 
17 Neutrophils  % 44.9 57.3 56.5 0.4 
18 Mix% 11.4 8.4 5.3 0.6 
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Figure (3-1):  Activity of glutathione peroxidase in platelets in males and females of 
Non-Thrombocytopenic, Thrombocytopenic malaria patients and healthy control 
group. 
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Figure (3- 2): The activity of the platelets GPx in different groups of age of Non-
Thrombocytopenic, Thrombocytopenic malaria patients and healthy control 
group.  
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Figure (3-3): Correlation betweenblood platelet count and platelet glutathione 
peroxidase (GPx) (r = -0.60; p < 0,001) in Non-Thrombocytopenic, Thrombocytopenic 
malaria patients and healthy control group. 
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Figure (3-4): Correlation between blood platelet count and platelet malondialdehyde 
(MDA) (r = -0.69; p < 0,001) in Non-Thrombocytopenic, Thrombocytopenic malaria 
patients and healthy control group. 
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Figure (3- 5): The concentration of MDA in Non-Thrombocytopenic, 
Thrombocytopenic malaria patients and healthy control group. 
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Table (2): Correlation of platelets, GPX, and MDA with blood indices and some chemical parameters in Non-Thrombocytopenic, 
Thrombocytopenic malaria patients and healthy control group. 
Correlations 
  
WBCs RBCs Hb Hct MCV MCH MCHC Plt Lymp Neu mix T. bilirubin D. bilirubin U.A Protein T Albumin gpx mda 
Platelets Pearson Correlation .359* -.079 -.431** -.491** -.602** -.468** -.042  -.205 .210 -.131 .267 .169 -.248 .254 .173 .602** -.696** 
Sig. (2-tailed) .023 .628 .006 .001 .000 .002 .798 
 
.205 .193 .422 .095 .298 .123 .113 .286 .000 .000 
N 40 40 40 40 40 40 40  40 40 40 40 40 40 40 40 40 40 
GPx Pearson Correlation .234 -.056 -.267 -.274 -.317* -.278 -.088 .602** -.109 .117 -.066  .124 .544 .262 .485 .008  -.364* 
Sig. (2-tailed) .146 .733 .095 .088 .046 .082 .591 .000 .505 .470 .684 .445 .667 .373 .904 .961 
 
.021 
N 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40  40 
MDA Pearson Correlation -.253 .037 .297 .371* .507** .361* -.038 -.696** .130 -.063 -.096 -.021 .026 .041 -.279 -.137 -.364*  
Sig. (2-tailed) .115 .820 .063 .018 .001 .022 .814 .000 .426 .698 .557 .900 .872 .804 .081 .398 .021 
 
N 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40  
*. Correlation is significant at the 0.05 level (2-tailed). 
               
**. Correlation is significant at the 0.01 level (2-tailed). 
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4.  Discussion 
 
The aim of this study was to investigate the levels of platelets GPx and 
MDA and their relation to other biochemical parameters in blood of 
thrombocytopenic patients mediate by P. falciparum infection.  
 
Results indicate that the activity of the platelets enzyme glutathione 
peroxidase (GPx) was very low in thrombocytopenic malaria patients 
(TCP) compared to malaria non-thrombocytopenic (NTCP) and control 
subjects. These results agreed with those obtained by Claudio et al (2008) 
who found increased activity of GPx in platelets of NTCP compared to 
TCP. 
 
The activity of the enzyme GPx was negatively correlated with platelets 
count. These results agreed with Claudio et al (2008) who studied GPx in 
platelets of patients with vivax malaria, the author stated that this may be 
due to increased lysis of platelets because of increased reactive oxygen 
species (ROS) and the low activity of GPx and low level of antioxidant. 
 
Thrombocytopenia was observed in humans and animals infected with 
malaria parasites. There are several mechanisms that have been proposed 
for occurrence of thrombocytopenia, which include disseminated 
intravascular coagulation, immune mechanisms due to absorption of 
soluble malaria antigen by platelets and subsequent attachment of 
antibodies to such antigens. Other studies suggested are defective platelet 
formation and hypersplenism and reactive oxygen species (ROS). 
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However, the exact mechanism has not been elucidated yet (Abdalla 1990, 
Kumar and Shashirekha 2006). 
 
The concentration of MDA was higher in the platelets of TCP relative to 
that of NTCP and control group. These results agree with study carried out 
by Sohail et al (2007) who found higher MDA levels in malaria patients 
infected with P. vivax patients.  
 
The increased amount of MDA generated during malaria infection may 
due to activation of the immune system (Pabón et al., 2003). The increase 
in lipid peroxidation is probably due to production of ROS species by the 
immune cells and also due to the synchronized O
-
2 during hemoglobin 
degradation by the malarial parasites. It has been shown that infected 
RBCs by P. falciparum trophozoites produce H2O2 and OH
-
 radicals twice 
as much as the normal erythrocytes (Sohail et al., 2007). 
 
The concentration of malondialdehyde (MDA) is negatively correlated 
with GPx; these results suggest the direct role of enzyme GPx to prevent 
formation of free radicals in humans (Claudio et al., 2008). 
 
The concentration of total bilirubin, conjugated bilirubin; total protein, 
albumin and uric acid were in normal range which may demonstrates an 
adequate capacity of plasma to protect its environment from free radical 
attack. Halliwell and Gutteridge (1999) found that the total oxidant status 
(TOS) of human plasma is mainly attributed to uric acid, protein and 
bilirubin.  
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Human protection against free radicals is by large distribution of free 
antioxidant with synergic reaction; the level of plasma antioxidant usually 
doesn’t reflect the antioxidant status (Claudio et al., 2008). It was reported 
that the total oxidative status activity of human is mainly ascribable to uric 
acid, albumin, total protein, and bilirubin (Halliwell and Gutteridge 1999). 
   
The complete hemogram were in normal range except the thrombocyte 
count which was low in TCP. 
  
Platelets membranes are less resistant to OS and the membranes of 
platelets are thinner than those of erythrocyte. Thus the lysis of platelets 
will be unavoidable, which may be increased by OS. Erel et al., (2001) 
found that platelet count, platelet superoxide dismutase and GPx activities 
of patients with P. vivax malaria infection were lower and platelets lipid 
peroxidation level were higher than normal controls, thus suggesting the 
OS as a possible cause of thrombocytopenia.   
 
 
Conclusion: 
The study concluded that the activity of glutathione peroxidase (GPx) is 
inversely relation to the infection of malaria and vice- versa for the 
malondialdehyde. Healthy females and (18 – 30 years) age group showed 
significantly higher (GPx) relative to other groups, whereas the difference 
between the same groups of the malaria patients was not significant. 
The findings of this study support the suggestion that reactive oxygen 
species may play an important role in pathogenesis of thrombocytopenia 
caused by infection of malaria parasite. 
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Recommendations: 
 Further studies are needed in order to clarify the association of OS and 
thrombocytopenia among Sudanese patients infected with P. 
falciparum malaria. 
 
 To investigate thrombocytopenia in patients infected with other 
parasites that cause malaria. 
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Appendix 
Appendix (I): classification of individuals according to platelets counts. 
   
GROUP 
Total control malaria 
PLT group low Count 0 10 10 
% within GROUP 
.0% 25.0% 20.0% 
normal Count 10 29 39 
% within GROUP 
100.0% 72.5% 78.0% 
high Count 0 1 1 
% within GROUP 
.0% 2.5% 2.0% 
Total Count 10 40 50 
% within GROUP 
100.0% 100.0% 100.0% 
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Appendix (II): The mean of all parameters participate in the study. 
No Parameter Malaria Control P value 
1.  Glutathione peroxidase ( U/l)  316.037 1979 0.000 
2.  Malondialdehyde (μmol/L) 4.8175 0.0230 0.021 
3.  TWBCs (X103 cell/ cmm) 7.203 6.060 0.02 
4.  RBCs (X106 cell/ cmm) 4.6267 4.4540 0.733 
5.  Hb (g/dl) 13.0025 12.5000 0.095 
6.  HCT (%) 39.163 37.850 0.088 
7.  MCV (fl/cell) 84.500 85.200 0.046 
8.  MCH  (pictogram/cell) 28.045 28.110 0.082 
9.  MCHC  (g/dl) 33.113 32.980 0.591 
10.  Thrombocytes count (X103 cell/ 
cmm) 
236.68 270.40 0.00 
11.  Lymphocytes % 36.893 38.160 0.505 
12.  Neutrophils  % 54.198 56.470 0.470 
13.  Mix% 9.135 5.370 0.684 
14.  Total bilirubin (mg/dl) 0.697 0.470 0.445 
15.  Direct bilirubin (mg/dl) 0.155 0.160 0.667 
16.  Uric acid (mg/dl) 5.583 5.57 0.373 
17.  Total protein (g/dl) 7.015 7.100 0.904 
18.  Albumin (g/dl) 4.030 4.040 0.961 
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Appendix (III): Total White Blood Cells in Non-Thrombocytopenic, Thrombocytopenic 
malaria patients and healthy control group in different study ages. 
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Appendix (IV): Total White Blood Cells count in in Non-Thrombocytopenic, 
Thrombocytopenic malaria patients and healthy control group.
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Appendix (V): Concentration of total bilirubin in in Non-Thrombocytopenic, 
Thrombocytopenic malaria patients and healthy control group. 
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Appendix (VI):  Concentration of direct bilirubin in Non-Thrombocytopenic, 
Thrombocytopenic malaria patients and healthy control group. 
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Appendix (VII): Uric acid concentration in in Non-Thrombocytopenic, 
Thrombocytopenic malaria patients and healthy control group. 
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 Appendix (VIII): Total protein concentration in Non-Thrombocytopenic, 
Thrombocytopenic malaria patients and healthy control group 
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Appendix (IX): Albumin concentration in Non-Thrombocytopenic, Thrombocytopenic 
malaria patients and healthy control group. 
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